Author:
Tsai Y-S,Shiau A-L,Chen Y-F,Tsai H-T,Tzai T-S,Wu C-L
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference40 articles.
1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712.
2. Hussain MH, MacVicar GR, Petrylak DP, Dunn RL, Vaishampayan U, Lara Jr PN et al. Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II national cancer institute trial. J Clin Oncol 2007; 25: 2218–2224.
3. Krüger S, Weitsch G, Büttner H, Matthiensen A, Böhmer T, Marquardt T et al. HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications. Int J Cancer 2002; 102: 514–518.
4. Tsai YS, Tzai TS, Chow NH, Yang WH, Tong YC, Lin JS et al. Prognostic values of p53 and HER-2/neu coexpression in invasive bladder cancer in Taiwan. Urol Int 2003; 71: 262–270.
5. Lonn U, Lonn S, Friberg S, Nilsson B, Silfversward C, Stenkvist B . Prognostic value of amplification of c-erb-B2 in bladder carcinoma. Clin Cancer Res 1995; 1: 1189–1194.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献